Literature DB >> 8210617

Lung deposition from four nebulizers.

J G Hardy1, S P Newman, M Knoch.   

Abstract

The total and regional deposition of aerosol has been compared using four nebulizers; the Pari Boy 37.80, Pari IS-2, RespirGard II and Penta-Sonic. The aerosol was radiolabelled with [99Tcm]DTPA, administered to ten healthy subjects and the distributions monitored by gamma scintigraphy. Median lung aerosol depositions expressed as percentages of the doses initially loaded into the nebulizers were: Pari IS-2 19%, Pari Boy 37.80 13%, RespirGard II 9% and Penta-Sonic 2%. The ratios of the peripheral to central lung deposition, however, were greater with the RespirGard II and Penta-Sonic nebulizers. The choice of the most appropriate nebulizer depends on the pharmaceutical being administered, since aerosol must be delivered to the required site in sufficient quantity, whilst minimizing the incidence of local or systemic side-effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8210617     DOI: 10.1016/0954-6111(93)90074-a

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  12 in total

Review 1.  Cough challenge in the assessment of cough reflex.

Authors:  A H Morice; J A Kastelik; R Thompson
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

2.  Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged.

Authors:  V L Silkstone; H S Tomlinson; S A Corlett; H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

Review 3.  Methods to identify drug deposition in the lungs following inhalation.

Authors:  H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  2001-04       Impact factor: 4.335

Review 4.  Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.

Authors:  N R Labiris; M B Dolovich
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

Review 5.  Nuclear medicine techniques in the evaluation of pharmaceutical formulations.

Authors:  A C Perkins; M Frier
Journal:  Pharm World Sci       Date:  1996-06

Review 6.  The science of nebulised drug delivery.

Authors:  C O'Callaghan; P W Barry
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

7.  SPECT-CT Comparison of Lung Deposition using a System combining a Vibrating-mesh Nebulizer with a Valved Holding Chamber and a Conventional Jet Nebulizer: a Randomized Cross-over Study.

Authors:  Jonathan Dugernier; Michel Hesse; Rita Vanbever; Virginie Depoortere; Jean Roeseler; Jean-Bernard Michotte; Pierre-François Laterre; François Jamar; Gregory Reychler
Journal:  Pharm Res       Date:  2016-11-07       Impact factor: 4.200

Review 8.  Pharmacological antioxidant strategies as therapeutic interventions for COPD.

Authors:  Irfan Rahman
Journal:  Biochim Biophys Acta       Date:  2011-11-09

9.  Evaluation of patient-reported outcomes and quality of life with the I-neb AAD system in patients with chronic obstructive pulmonary disease.

Authors:  Nicola Goodman; Mike Morgan; Kurt Nikander; Sarah Hinch; Steven Coughlin
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-04       Impact factor: 2.849

Review 10.  Pharmacokinetic optimisation of asthma treatment.

Authors:  A M Taburet; B Schmit
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.